Biotech Updates

Limited Release of GM Clover in Australia

October 17, 2008

The Australian Office of the Gene Technology Regulator (OGTR) has received an application for the limited and controlled release of clover genetically modified to resist infection by the alfalfa mosaic virus from the Victorian Department of Primary Industries (DPI). The purpose of the trial is to conduct experiments to evaluate the agronomic performance, including seed yield, of the GM white clover line under field conditions. The transgenic line harbors a virus resistance gene from a common gut bacterium and the antibiotic resistance marker gene nptII. OGTR has prepared a Risk Assessment and Risk Management Plan (RARMP) for this application, which concludes that the proposed release poses negligible risks to people and the environment.

If approved, the trial will be conducted at one site in New South Wales, on a maximum area of 633 m2 from 2009 to 2011. DPI is bound to adopt certain measures to restrict the dissemination of GM plant materials, such as surrounding the trial site with a pollen trap and postharvest monitoring of fields.

For more information, visit http://www.ogtr.gov.au/internet/ogtr/publishing.nsf/Content/dir089-2008